News
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback